ClinicalTrials.Veeva

Menu

Sustained Aeration of Infant Lungs Trial (SAIL)

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Extreme Prematurity
Preterm Birth

Treatments

Procedure: Sustained Inflation
Procedure: Standard of Care

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02139800
819208
1U01HD072906-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study is a 2-arm randomized, controlled, multi-center clinical trial to determine which of two strategies at birth are best to optimally aerate the lung of preterm infants. Specifically we will determine in 600 infants of 23-26 weeks gestational age (GA) requiring respiratory support at birth which of two lung opening strategies - either a standard PEEP/CPAP of 5-7 cm H2O in the delivery room (DR), as compared to early lung recruitment using Sustained Inflation (SI) in the DR, will result in a lower rate of the combined endpoint of death or bronchopulmonary dysplasia (BPD) at 36 weeks gestational age.

Hypotheses:

  1. Early lung recruitment with SI superimposed upon standard PEEP/CPAP in the DR will reduce the need for mechanical ventilation in the first seven days of life, and reduce need for surfactant use; and
  2. A policy of DR SI on standard PEEP/CPAP recruitment will confer better outcomes at 36 weeks post-menstrual age (PMA) than standard PEEP/CPAP

Full description

The SAIL trial aims to provide evidence for changing policy or standard of care. The context of this trial is an unacceptable rate of poor long-term outcomes of preterm infants born as Extremely Low Gestational Age Newborns (ELGAN) <1000 g birthweight (BW), but especially for those born between 23-26 weeks' gestational age (GA). Such infants are the most vulnerable and immature in all organ systems, including the lungs and the brain. These infants are at high risk of death and bronchopulmonary dysplasia (BPD) during their initial hospitalization, neurodevelopmental impairment (NDI) and pulmonary problems in infancy and childhood.

The SAIL trial focuses on facilitating the difficult transition of these most vulnerable infants from a liquid filled in-utero lung to an ex-utero air-filled lung. Sustained Inflation (SI) is a promising delivery room (DR) intervention, with evidence of short-term efficacy with minimal risk of additional harm beyond current standard accepted Newborn Resuscitation Program (NRP) Guidelines. This protocol proposes a fully informed consenting procedure. We propose to evaluate the impact of a SI in the DR on the need for mechanical ventilation in the first week of life which would also impact mortality rates and the incidence and severity of BPD.

Enrollment

460 patients

Sex

All

Ages

23 to 26 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age (GA) at least 23 weeks but less than 27 completed weeks by best obstetrical estimate
  • Requiring resuscitation/respiratory intervention at birth -"apneic, labored breathing, gasping" (as defined in NRP 2011 AAP 6th Edition p.45)

Exclusion criteria

  • Considered non-viable by the attending neonatologist
  • Refusal of antenatal informed consent
  • Known major anomalies, pulmonary hypoplasia
  • Mothers who are unable to consent for their medical care and who do not have a surrogate guardian will not be approached for consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

460 participants in 2 patient groups

Control Arm-Standard of care
Active Comparator group
Description:
Control Arm-Respiratory support using Standard of Care positive-end expiratory pressure/continuous positive airway pressure (PEEP/CPAP) of 5-7 cm H2O compared to Sustained Inflation intervention
Treatment:
Procedure: Standard of Care
Sustained Intervention
Experimental group
Description:
Administer delivery room respiratory support using a Sustained Inflation (SI) intervention and expiratory pressure/continuous positive airway pressure (PEEP/CPAP) of 5-7 cm H2O
Treatment:
Procedure: Sustained Inflation

Trial documents
2

Trial contacts and locations

21

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems